NZ telco Chorus is in dire straits, but is it too cheap to refuse?

It's make or break time for the company involved in building New Zealand's fibre network.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

It's been a great year for most companies on the S&P/ASX 200 (ASX: XJO) (^AXJO) this year, but it's not beer and skittles for everyone.

Shares in New Zealand telecommunication company Chorus (ASX: CNU) have hit an all-time low as the threat of government regulation on the price the company can charge customers looms overhead.

The company has said that under the fixed pricing proposed by the government, the lower cash flows will make it harder to borrow the money it needs to continue to build the country's fibre-optic network for ultra-fast broadband, a project being co-ordinated in conjunction with government.

Shares in Chorus have plunged almost 18% since Monday. One big risk being contemplated by investors is whether the company can continue to pay a dividend if its cash flow is reduced, or if the company's credit rating is downgraded.

Yesterday, two investment rating agencies, Moody's and Standard & Poors, placed Chorus on credit rating watch for possible downgrades, which has the potential to increase the company's borrowing costs. These borrowing costs are substantial given it is the initial phase of the company's programme to construct a fibre-optic network across the country.

And Chorus is not getting any sympathy from the government's opposition. Labour's economic development spokesman Shane Jones has blasted the company. "Chorus did the deal; it's called capitalism. They have continued to pay dividends. They have got a contract. They are not the first company to go through a peak in capital investment", Mr. Jones is quoted as saying by Fairfax media.

So is this an ideal opportunity to buy while there is blood in the streets? At a price-to-earnings ratio of just 5, and strong potential growth it certainly looks attractive. However it is entirely possible that the dividend will be curbed or cut going forward, and the continued regulatory issues make evaluating future potential extremely difficult.

Foolish Takeaway

New Zealand is always going to need the fibre-optic network built, and Chorus is still the company charged with the job. However the breakdown in the partnership between the government and the company looks like it could take a serious toll on the company's short-term prospects, with an unclear impact on the long term.

Motley Fool contributor Regan Pearson does not own shares in any of the companies mentioned. 

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »